Showing 321 - 340 results of 18,030 for search '(( significantly ((nn decrease) OR (a decrease)) ) OR ( significantly reported decrease ))', query time: 0.51s Refine Results
  1. 321
  2. 322
  3. 323

    S8 File - by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  4. 324

    Study populations of included studies. by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  5. 325

    Future research directions. by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  6. 326

    PRISMA flow diagram. by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  7. 327

    S9 File - by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  8. 328

    S7 File - by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  9. 329

    Participant characteristics of included studies. by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  10. 330

    GLM models for predictors of monthly HIV costs. by Drew B. Cameron (10687420)

    Published 2024
    “…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …”
  11. 331

    Median cost (USD) per visit breakdown. by Drew B. Cameron (10687420)

    Published 2024
    “…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …”
  12. 332
  13. 333
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339

    NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission. by Jinwei Zhang (462455)

    Published 2025
    “…The inhibitory synaptic density of NgR1 mice showed a significant decrease when compared to WT mice (***P <  0.001). …”
  20. 340